Medicine
Cyproheptadine 2 mg/5 mL syrup
Cyproheptadine 2 mg/5 mL syrup is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F) excursion permitted to 15° to 30°C (59° to…
Key facts
- Active ingredient (INN)
- Cyproheptadine
- Brand
- Sold under the generic name
- Strength
- 2 mg/5 mL
- Dosage form
- Syrup
- Route
- Oral
- Packs
- 120 syringes, 473 mL, 946 mL and 2 more
- Manufacturers
- Chartwell RXAtlantic BiologicalRising Pharma HoldingsTris Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F) excursion permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R06AX02 Cyproheptadine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 July 2006
- Identifiers
- RxCUI 866021DailyMed set ID 37fe7264-4d45-4d6c-ac13-40fcd1d82351, e2bf4d46-6585-41d9-868c-98603b165d5b, 50b3abc0-d86a-e8f5-e063-6394a90ad25e +1NDC 62135-949, 64980-504, 17856-0504 +1Application ANDA203191, ANDA040668, ANDA205431
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 120 syringe in 1 case / 2.5 mL in 1 syringe | 17856-0504-1 | Atlantic Biological | 30 April 2026 |
| 473 mL in 1 bottle | 62135-949-47 | Chartwell RX | 13 July 2022 |
| 946 mL in 1 bottle | 62135-949-94 | Chartwell RX | 13 July 2022 |
| 473 mL in 1 bottle | 64980-504-48 | Rising Pharma Holdings | 10 July 2006 |
| 473 mL in 1 bottle, plastic | 27808-099-01 | Tris Pharma | 30 December 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 October 1961 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cyproheptadine
Clinical summary
Cyproheptadine is a prescription medicine. It is available as tablets, oral solution and syrup. MedsAcross supplies Cyproheptadine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CyproheptadineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CYPROHEPTADINE HYDROCHLORIDE prescribing information (Pangea Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Cyproheptadine 2 mg/5 mL syrup for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.